Loading
A phase 3 trial of Cytarabine, Daunorubicin, Etoposide and Clofarabine in Acute myeloid leukaemia, run by St. Jude Children's Research Hospital, completed.
Clofarabine Plus Cytarabine Versus Conventional Induction Therapy And A Study Of NK Cell Transplantation In Newly Diagnosed Acute Myeloid Leukemia is a phase 3 interventional study registered as NCT00703820 by St. Jude Children's Research Hospital, with 324 participants recorded, started 2008-08-04 and reaching its primary completion in 2017-03-30. Interventions recorded: Cytarabine, Daunorubicin, Etoposide, Clofarabine, CliniMACS. Conditions recorded: Acute Myeloid Leukemia.
Linked to the drug Clofarabine because the registry names it among its interventions and Acute myeloid leukaemia among its conditions. Registry record only: no result has been read by an editor.
Shares Clofarabine, Acute myeloid leukaemia and the tag pipeline.
Shares Daunorubicin, Cytarabine, Acute myeloid leukaemia and the tag pipeline.
Shares Daunorubicin, Cytarabine and the tag pipeline.
Shares Daunorubicin, Cytarabine, Etoposide, Acute myeloid leukaemia and the tag pipeline.
Shares Daunorubicin, Cytarabine, Etoposide and the tag pipeline.
Shares Daunorubicin, Cytarabine, Acute myeloid leukaemia and the tag pipeline.
Shares Clofarabine, Daunorubicin, Cytarabine, Etoposide and the tag pipeline.
Shares Daunorubicin, Acute myeloid leukaemia and the tag pipeline.